Link: https://precisiononcology.exactsciences.com/healthcare-providers/treatment-determination/breast-cancer/oncotype-dx-breast-recurrence-score
Description: WebThe Oncotype DX Breast Recurrence Score ® test provides personalized genomic insights for early-stage HR+, HER2- breast cancer patients. OVERVIEW. CLINICAL EVIDENCE. TEST COMPARISON. INTERPRETING THE RESULTS. RESOURCES. Order a Test. The only test proven to predict likelihood of chemotherapy benefit 1,2.
DA: 89 PA: 15 MOZ Rank: 77
Link: https://www.breastcancer.org/screening-testing/oncotype-dx
Description: WebThe Oncotype DX Breast Recurrence Score Test is used in two ways: to help doctors figure out a person’s risk of early-stage, estrogen receptor-positive breast cancer coming back in a part of the body away from the breast (distant recurrence) to help figure out if a person will benefit from chemotherapy.
DA: 36 PA: 9 MOZ Rank: 28
Link: https://www.komen.org/breast-cancer/diagnosis/factors-that-affect-prognosis/oncotype-dx/
Description: WebApr 11, 2024 · Oncotype DX is the most common tumor profiling test used in the U.S. and the only one used in breast cancer staging. Other tumor profiling tests, such as MammaPrint ®, are available. Oncotype DX testing. Oncotype DX tests a sample of the tumor (removed during a biopsy or surgery) for a group of 21 genes.
DA: 51 PA: 87 MOZ Rank: 86
Link: https://www.exactsciences.com/Our-Tests/Oncotype
Description: Web1 Exact Sciences Estimates. Oncotype genomic tests provide physicians and patients with personalized insights, allowing them to make treatment decisions with a greater degree of confidence.
DA: 69 PA: 15 MOZ Rank: 16
Link: https://www.mskcc.org/cancer-care/patient-education/oncotype-dx
Description: WebJun 22, 2023 · What is the Oncotype DX test? The Oncotype DX is a test that looks at genes in breast cancer tissue. It may predict: Breast cancer prognosis (prog-NO-sis). Prognosis is the chance of the cancer coming back. If cancer comes back, it’s …
DA: 71 PA: 38 MOZ Rank: 97
Link: https://www.oncotypeiq.com/en-GB/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test
Description: WebThe Oncotype DX Breast Recurrence Score ® test has been developed for patients with early-stage HR+, HER2- breast cancer to: Identify those patients who will derive benefit from chemotherapy. Determine the magnitude of chemotherapy benefit. Make chemotherapy a personalised treatment.
DA: 74 PA: 26 MOZ Rank: 1
Link: https://precisiononcology.exactsciences.com/
Description: WebThe Oncotype DX ® tests deliver clinically relevant genomic intelligence specific to the individual biology of a patient’s tumor—equipping physicians with the Exact insights they need. Breast Cancer Tests. Colon Cancer Tests. Therapy Selection.
DA: 7 PA: 7 MOZ Rank: 4
Link: https://breastcancernow.org/about-breast-cancer/diagnosis/oncotype-dx/
Description: WebOncotype DX is a test that predicts how likely breast cancer is to spread to somewhere else in the body (secondary breast cancer) within 10 years of diagnosis, in people who will be taking hormone therapy for at least 5 years. 2. Who is Oncotype DX for? The test is suitable for people recently diagnosed with early stage. invasive.
DA: 11 PA: 97 MOZ Rank: 71
Link: https://www.oncotypeiq.com/en-IE/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/about-the-test
Description: WebOverview. Oncotype DX Breast Recurrence Score. The Oncotype DX assay is a 21-gene assay that predicts the likelihood of chemotherapy benefit and 10-year risk of distant recurrence to inform adjuvant treatment decisions in certain women with early-stage invasive breast cancer. The Oncotype DX Assay:
DA: 15 PA: 21 MOZ Rank: 85
Link: https://www.oncolink.org/cancers/breast/screening-diagnosis/the-oncotype-R-dx-breast-recurrence-score
Description: WebOncotype Dx ® is a genomic lab test that helps guide treatment choices for people with early-stage invasive breast cancers. This test helps decide if using chemotherapy along with hormone (endocrine) therapy after surgery will lower your risk of your cancer coming back (recurring). Genomic tests are not the same as genetic tests.
DA: 29 PA: 90 MOZ Rank: 82
